Clinical Trial Site

Norwalk, Connecticut 06856

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Iron Deficiency Anemia

Studies at this site

• A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer — Completed
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed